PMGC HOLDINGS INC. Disposal Group, Including Discontinued Operation, Operating Expense
PMGC HOLDINGS INC. (ELAB) reported Disposal Group, Including Discontinued Operation, Operating Expense of $144.19 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense · last filed 2026-08-14
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for the quarter ending 2025-12-31 was $1.80K, a 99.75% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for the quarter ending 2025-09-30 was $83.00, a 99.99% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for the quarter ending 2025-06-30 was $7.66K, a 99.41% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for the quarter ending 2025-03-31 was $134.64K, a 89.87% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for fiscal 2025 was $144.19K, a 96.43% decline from fiscal 2024.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for fiscal 2024 was $4.04M, a 7.47% increase from fiscal 2023.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, operating expense for fiscal 2023 was $3.76M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Expense 3 month | Disposal Group, Including Discontinued Operation, Operating Expense 6 month | Disposal Group, Including Discontinued Operation, Operating Expense 9 month | Disposal Group, Including Discontinued Operation, Operating Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.89K derived: sum of 2 quarters · filed 2026-03-30 | $9.55K derived: sum of 3 quarters · filed 2026-08-14 | $144.19K 10-K · filed 2026-03-30 |
| 2025-09-30 | $83.00 10-Q · filed 2025-11-14 | $7.74K derived: sum of 2 quarters · filed 2026-08-14 | $142.38K 10-Q · filed 2025-11-14 | $874.18K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $7.66K 10-Q · filed 2026-08-14 | $142.30K 10-Q · filed 2026-08-14 | $874.10K derived: sum of 3 quarters · filed 2026-08-14 | $1.56M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $134.64K 10-Q · filed 2026-05-15 | $866.43K derived: sum of 2 quarters · filed 2026-05-15 | $1.55M derived: sum of 3 quarters · filed 2026-05-15 | $2.85M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $731.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.42M derived: sum of 2 quarters · filed 2026-03-30 | $2.71M derived: sum of 3 quarters · filed 2026-03-30 | $4.04M 10-K · filed 2026-03-30 |
| 2024-09-30 | $688.12K 10-Q · filed 2025-11-14 | $1.98M derived: sum of 2 quarters · filed 2025-11-14 | $3.31M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.29M 10-Q · filed 2025-08-13 | $2.62M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $1.33M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $3.76M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |